LDLR and atherosclerosis: To test this hypothesis, we applied cell‐penetrating cSN50.1 peptide, a nuclear transport modifier (NTM), to the model of accelerated atherosclerosis in low‐density lipoprotein (LDL) receptor‐deficient (ldlr−/−) mice.